Insufficient scRNA-seq data for expression of CHST5 at single-cell level.
Insufficient scRNA-seq data for expression of CHST5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 90% | 1512.63 | 873 / 966 | 47% | 2.43 | 249 / 527 |
stomach | 67% | 74.21 | 241 / 359 | 38% | 1.71 | 108 / 286 |
brain | 99% | 298.15 | 2626 / 2642 | 2% | 0.02 | 13 / 705 |
prostate | 91% | 67.73 | 222 / 245 | 0% | 0 | 0 / 502 |
uterus | 86% | 75.36 | 147 / 170 | 1% | 0.03 | 3 / 459 |
ovary | 85% | 66.94 | 153 / 180 | 1% | 0.01 | 5 / 430 |
thymus | 86% | 57.26 | 560 / 653 | 0% | 0 | 0 / 605 |
kidney | 78% | 43.63 | 69 / 89 | 0% | 0.01 | 1 / 901 |
bladder | 52% | 21.19 | 11 / 21 | 10% | 0.44 | 50 / 504 |
heart | 62% | 33.74 | 531 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 55% | 27.17 | 143 / 258 | 0% | 0 | 0 / 230 |
lung | 49% | 44.54 | 283 / 578 | 6% | 0.28 | 64 / 1155 |
esophagus | 34% | 17.41 | 495 / 1445 | 20% | 1.37 | 36 / 183 |
spleen | 50% | 23.61 | 121 / 241 | 0% | 0 | 0 / 0 |
breast | 48% | 29.23 | 222 / 459 | 0% | 0 | 0 / 1118 |
pancreas | 25% | 12.03 | 82 / 328 | 8% | 0.28 | 14 / 178 |
skin | 28% | 12.01 | 501 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 20% | 8.78 | 272 / 1335 | 0% | 0 | 0 / 0 |
adipose | 20% | 8.32 | 244 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 7% | 3.08 | 67 / 929 | 0% | 0 | 0 / 0 |
liver | 2% | 0.71 | 4 / 226 | 1% | 0.08 | 6 / 406 |
muscle | 2% | 0.72 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006044 | Biological process | N-acetylglucosamine metabolic process |
GO_0006790 | Biological process | sulfur compound metabolic process |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0006477 | Biological process | protein sulfation |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0008146 | Molecular function | sulfotransferase activity |
GO_0001517 | Molecular function | N-acetylglucosamine 6-O-sulfotransferase activity |
Gene name | CHST5 |
Protein name | Carbohydrate sulfotransferase 5 Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha) (GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3) |
Synonyms | |
Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues and O-linked sugars of mucin-type acceptors. Acts on the non-reducing terminal GlcNAc of short carbohydrate substrates. However, it does not transfer sulfate to longer carbohydrate substrates that have poly-N-acetyllactosamine structures. Has no activity toward keratan. Not involved in generating HEV-expressed ligands for SELL. Its substrate specificity may be influenced by its subcellular location. . |
Accessions | Q9GZS9 H3BMG8 ENST00000565039.1 ENST00000336257.8 [Q9GZS9-1] |